The UK FMD Working Group for Community Pharmacy has responded to the Medicines and Healthcare products Regulatory Agency (MHRA) consultation on implementing safety features under FMD.
The response is available from the National Pharmacy Association press office and will be posted on the working group’s website.
Speaking after a meeting of the working group, where the response was finalised, working group chair Raj Patel, said:
“The working group’s position has not changed and we urge people to engage with FMD. The community pharmacy sector needs to move quickly.
“Irrespective of any Brexit confusion and whatever our post-Brexit position might be, we need to have a viable solution by the February 9 deadline.
“FMD aims to make medicine falsification detectable and uneconomic. We recognise contractors will need to make substantial time and investment, but it is important that community pharmacy meets its obligations.
“I urge all community pharmacies to start planning for FMD now.”